Skip to content
DataLookout
Menu

HELIXNCT06948773

A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria shortened, about 3 words
    • Trial completed
    • Primary and study completion dates changed from estimate of Sep 30, 2026 to Sep 7, 2026
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  3. Minor Start date changed from estimate of May 30, 2025 to May 21, 2025v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 30, 2025 to May 30, 2025
    • Site details revised
    v3
  5. Notable Primary endpoint revised
    • Study title revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

≥ 20% change from baseline in mean IOP at the 3-month post-operative endpoint
Timeframe: 3 months

Secondary (2)

Change in mean IOP
Average number of ocular hypotensive medications

Arms and interventions

POAG and CataractsExperimental

Subjects diagnosed with mild to moderate primary open angle glaucoma (POAG) and cataracts in the study eye.

Devices: Helix Surgical System

Sites

1 site in 1 country

  • Panama Eye CenterPanama City, Panama